Every drug has a journey

Healthcare reimbursement is an ever-changing environment, never more so than in today’s new marketplaces. With so many nuances in the implementation of reimbursement techniques and methodologies, combined with the impact of the Affordable Care Act, each day brings new challenges—and opportunities.

We thrive in this environment. We understand the implications of reimbursement on sales and marketing strategies. We know how systems work, who influences them, and how to optimize appropriate patient access to biopharmaceuticals, medical devices, diagnostics, and services.

Our clients tell us that we are uniquely adept at researching and analyzing information and skilled at turning research findings into strategic messages, initiatives, and long-term marketing plans. This reflects our staff’s experience in the launch process, sales, marketing, new business development, payer relations, and reimbursement planning that spans the entire biopharmaceutical and medical device industry.

Denise Pierce, President

Denise Pierce, President

DK Pierce is anything but standard; we customize our services to meet your needs and your product market environment. And I personally guarantee that we’ll provide enthusiasm, expertise, and exceptional outcomes, as we have for dozens of clients over the last 15 years.


We'd love to help you. Give us a call at (317) 873-0303.

Send us a message
  • This field is for validation purposes and should be left unchanged.
  • What makes us unique?
  • Deep Payer & Reimbursement Expertise
    Deep Payer & Reimbursement Expertise
  • Personalized Solutions
    Personalized Solutions
  • Attentive & Responsive Service
    Attentive & Responsive Service
  • Meaningful Results
    Meaningful Results
News & Insights
Quality of Coverage: Getting the Answers You Need
I want you to picture your favorite book. Maybe it’s...
Business Health Coalitions: 5 Key Takeaways Influencing Specialty Drugs
It’s no secret that the world of healthcare and pharmaceuticals...
4 Advisor and Research Must-Haves to Get Results
Launching and sustaining a rare disease drug, oncology treatment or...
DKP to be Employee-Owned: What that Means for You and Us
Recently CEO Denise announced that DKP is embarking on a...
BI Gone Wrong: 5 Pitfalls to Avoid with Consultants or DIY
Developing rare disease and oncology drugs is intricate work in...
View All News & Insights
A few areas of our expertise
  • Product Launch
  • Competitive Reimbursement Analysis
  • Payer Relations, Notifications, and New Drug Applications
  • National/Local Payer Strategies
  • Reimbursement Planning and Training
  • Qualitative Stakeholder Research and Analysis
  • Strategic Market Monitoring
  • Payer Policy Monitoring
  • Compendia Services
  • Advisory Boards
Learn More